INTERNATIONAL PATENT: QIHAN HONG KONG LIMITED FILES APPLICATION FOR "IMMUNOTHERAPIES USING ENGINEERED CELLS FOR ENHANCED BONE MARROW HOMING"

GENEVA, Nov. 17 -- QIHAN HONG KONG LIMITED (Rm 1902, Easey Comm. Bldg., 253-261 Hennessy Road, WanchaiHong Kong 999077) filed a patent application (PCT/CN2025/093367) for "IMMUNOTHERAPIES USING ENGINEERED CELLS FOR ENHANCED BONE MARROW HOMING" on May 08, 2025. With publication no. WO/2025/232819, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HE, Xiangjun (Chuanhuakechuang Mansion B204, Xiaoshan Innovation Polis, Xiaoshan DistrictHangzhou, Zhejiang 311200), ZENG, Wenxiu (Chuanhuakechuang Mansion B204, Xiaoshan Innovation...